SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms

SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms

There has been limited research on the role of the mucosal immune response to SARS-CoV-2 infection. Here, the authors perform a prospective observational household study and find that mucosal antibody responses are associated with decreased viral load and faster resolution of systemic symptoms.

Bibliographic Details
Main Authors: Janeri Fröberg, Joshua Gillard, Ria Philipsen, Kjerstin Lanke, Joyce Rust, Diana van Tuijl, Karina Teelen, Teun Bousema, Elles Simonetti, Christa E. van der Gaast-de Jongh, Mariska Bos, Frank J. van Kuppeveld, Berend-Jan Bosch, Marrigje Nabuurs-Franssen, Nannet van der Geest-Blankert, Charlotte van Daal, Martijn A. Huynen, Marien I. de Jonge, Dimitri A. Diavatopoulos
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-25949-x

Internet

https://doi.org/10.1038/s41467-021-25949-x

Similar Items